CVS Health Co. (NYSE:CVS) Stake Trimmed by Marathon Trading Investment Management LLC

Marathon Trading Investment Management LLC lowered its stake in CVS Health Co. (NYSE:CVS) by 41.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,900 shares of the pharmacy operator’s stock after selling 10,000 shares during the quarter. Marathon Trading Investment Management LLC’s holdings in CVS Health were worth $874,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the stock. Claro Advisors LLC grew its stake in CVS Health by 27.1% during the 3rd quarter. Claro Advisors LLC now owns 12,024 shares of the pharmacy operator’s stock valued at $756,000 after acquiring an additional 2,563 shares in the last quarter. AM Squared Ltd purchased a new position in CVS Health during the 3rd quarter valued at about $88,000. BCGM Wealth Management LLC grew its stake in CVS Health by 2.1% during the 3rd quarter. BCGM Wealth Management LLC now owns 23,253 shares of the pharmacy operator’s stock valued at $1,462,000 after acquiring an additional 476 shares in the last quarter. Seizert Capital Partners LLC lifted its holdings in shares of CVS Health by 3.5% during the 3rd quarter. Seizert Capital Partners LLC now owns 463,819 shares of the pharmacy operator’s stock valued at $29,165,000 after buying an additional 15,811 shares during the last quarter. Finally, Vaughan Nelson Investment Management L.P. lifted its holdings in shares of CVS Health by 16.8% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 34,285 shares of the pharmacy operator’s stock valued at $2,156,000 after buying an additional 4,920 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the subject of several research reports. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a report on Thursday. Truist Financial lifted their price target on CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a report on Friday, October 11th. Deutsche Bank Aktiengesellschaft reduced their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. Wells Fargo & Company reduced their target price on CVS Health from $61.00 to $60.00 and set an “equal weight” rating for the company in a report on Monday, November 4th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, eight have given a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $72.44.

CVS Health Stock Performance

CVS opened at $53.19 on Friday. The stock has a market cap of $66.93 billion, a PE ratio of 13.50, a P/E/G ratio of 0.92 and a beta of 0.55. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 1 year low of $52.71 and a 1 year high of $83.25. The stock’s 50 day simple moving average is $59.23 and its 200-day simple moving average is $58.66.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the business posted $2.21 earnings per share. Sell-side analysts forecast that CVS Health Co. will post 5.48 EPS for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 5.00%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.